Patents by Inventor Guillermo E. Sanchez

Guillermo E. Sanchez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230165291
    Abstract: Disclosed are nutraceutical formulations, and methods of using these nutraceutical formulations for the mitigation of chronic malnutrition in an infant, wherein the infant is breast feeding from a lactating mother ingesting one or more of said nutraceutical formulations in accordance with a prescribed regimen.
    Type: Application
    Filed: December 12, 2022
    Publication date: June 1, 2023
    Inventors: Glenn H. Sullivan, Guillermo E. Sanchez
  • Publication number: 20230115385
    Abstract: Disclosed are nutraceutical formulations, including extracts comprising the hydrophilic and lipophilic fractions of stabilized rice bran. Also disclosed are methods for using said nutraceutical formulations for the management or remediation of conditions related to type II diabetes in humans, including methods for decreasing HbA1c and fasting glucose blood concentrations, and for increasing serum fasting insulin levels.
    Type: Application
    Filed: November 23, 2022
    Publication date: April 13, 2023
    Inventors: Glenn H. Sullivan, Guillermo E. Sanchez
  • Patent number: 11547135
    Abstract: Disclosed are nutraceutical formulations, and methods of using these nutraceutical formulations for the mitigation of chronic malnutrition in an infant, wherein the infant is breast feeding from a lactating mother ingesting one or more of said nutraceutical formulations in accordance with a prescribed regimen.
    Type: Grant
    Filed: September 18, 2019
    Date of Patent: January 10, 2023
    Inventors: Glenn H. Sullivan, Guillermo E. Sanchez
  • Patent number: 11540546
    Abstract: Disclosed are nutraceutical formulations, including extracts comprising the hydrophilic and lipophilic fractions of stabilized rice bran. Also disclosed are methods for using said nutraceutical formulations for the management or remediation of conditions related to type II diabetes in humans, including methods for decreasing HbA1c and fasting glucose blood concentrations, and for increasing serum fasting insulin levels.
    Type: Grant
    Filed: September 17, 2019
    Date of Patent: January 3, 2023
    Inventors: Glenn H. Sullivan, Guillermo E. Sanchez
  • Publication number: 20220054577
    Abstract: Disclosed are nutraceutical compositions and formulations, and methods of using bioactive nutraceutical compositions and formulations of enzymatically hydrolyzed stabilized rice bran extract for the improvement of maternal breast milk, and for the mitigation of chronic malnutrition in infants, wherein the infant is breast feeding from a lactating mother ingesting said nutraceutical compositions or formulations in accordance with a prescribed regimen.
    Type: Application
    Filed: August 18, 2021
    Publication date: February 24, 2022
    Inventors: Glenn H. Sullivan, Guillermo E. Sanchez
  • Publication number: 20200253259
    Abstract: Disclosed are nutraceutical formulations, including extracts comprising the hydrophilic and lipophilic fractions of stabilized rice bran. Also disclosed are methods for using said nutraceutical formulations for the management or remediation of conditions related to type II diabetes in humans, including methods for decreasing HbA1c and fasting glucose blood concentrations, and for increasing serum fasting insulin levels.
    Type: Application
    Filed: September 17, 2019
    Publication date: August 13, 2020
    Inventors: Glenn H. Sullivan, Guillermo E. Sanchez
  • Publication number: 20200008455
    Abstract: Disclosed are nutraceutical formulations, and methods of using these nutraceutical formulations for the mitigation of chronic malnutrition in an infant, wherein the infant is breast feeding from a lactating mother ingesting one or more of said nutraceutical formulations in accordance with a prescribed regimen.
    Type: Application
    Filed: September 18, 2019
    Publication date: January 9, 2020
    Inventors: Glenn H. Sullivan, Guillermo E. Sanchez